177 results found.
BARE BONES® - July 26, 2012
CONMED posted 2Q12 orthopaedic product sales of US $118.2MM, +9% from 2Q11. (Arthroscopy $81.0MM, +15%; Powered Instruments $37.2MM, -3%) (Growth reflects constant currency.) ...
BARE BONES® - July 20, 2012
Exactech and CONMED will co-develop comprehensive surgeon education to address advancements in patient care for shoulder and knee repair, from early arthroscopic intervention to total ...
First Look at Quarterly Results: 1Q12 vs. 1Q11
ORTHOWORLD’s preliminary estimates place overall 1Q12 market growth at 3% over 1Q11, as shown in Exhibit 1. Performance highlights follow and pertain to 1Q12, unless noted otherwise. Exhibit 1 Orthopaedic Sales1 Increase...
BARE BONES® - April 26, 2012
CONMED posted 1Q12 orthopaedic product sales of US $124.8MM, +10% from 1Q11. (Arthroscopy $86.2MM, +14%; Powered Instruments $38.6MM, +0.8%) (Growth reflects constant currency...
Continuing 2011 Results, Including AAOS Conference Highlights
The orthopaedic industry appears to be tilting its focus from implant materials and toward implant alignment and personalization, per analyst review of the 2012 meeting of the American Academy of Orthopaedic Surgeons (AAOS). On the floor and in recent earnings calls, companies noted observatio...
BARE BONES® - February 15, 2012
CONMED posted 2011 orthopaedic sales of US $437.8MM, +
BARE BONES® - February 7, 2012
CONMED's new product launches for this week include the CONMED Linvatec Hip Preservation instrumentation system; Y-KNOT™, reportedly the smallest "all suture" anchor on the market; XACTPIN™
BARE BONES® - January 3, 2012
CONMED Linvatec will serve as the exclusive worldwide marketing partner for Musculoskeletal Transplant Foundation's (MTF) sports medicine allograft tissues. CONMED Linvatec will also assume responsibility for global di...
3Q11: A First Look at Financials: ConMed
CONMED $104.2MM, +1% * Arthroscopy $69.4MM, -1% (Single-use $54.4MM, +6%; Capital $15MM, -21%) * Powered Instruments $34.8MM, -2% (Single-use $18.7MM, -3%; Capital $16.1MM, -1%) * Sports med bolstered by new products (SRS Shoulder Repair, Se...
BARE BONES® - September 15, 2011
CONMED LINVATEC launched the GENESYS™ Matryx® Biocomposite Interference Screw, indicated for soft tissue fixation in anterior and posterior cruciate ligament reconstruction and reattachment of soft tissue to bone. (CONMED Corporation, 8/26/11)
BARE BONES® - September 11, 2011
ORTHOPAEDIC STRATEGIC INITIATIVES CANNUFLOW and SYMMETRY MEDICAL have terminated their U.S. distribution agreement. Cannuflow products are available directly from Cannuflow and through authorized sales reps. (Cannuflow Inc., 8/19/11) CEREMED entered in...
First Look at 2Q11 Results: ConMed
CONMED $108.9MM, -3% * Arthroscopy $70.6MM, -8% * Powered Instruments $38.3MM, +58%
First Look at 1Q11 Results: ConMed
CONMED $113.5MM, +6% * Arthroscopy $75.4MM, +5% (Single-use devices +6%, Capital equipment +10%) * Powered Instruments $38.1MM, +9% (Handpieces ~20%, Generators +15%, Video Systems flat)  *Global economic pressures will continue to impact gr...
BARE BONES® - March 15, 2011
CONMED LINVATEC’s new product launches for 2011 include the Concept® Suture Passer, Sequent™ Meniscal Repair System, CrossFT BC™ Biocomposite Suture Anchor for Rotator Cuff Repair and PRO6140/PRO6240 Pin Drivers. (CONMED Corporation, 2/15/11)
Orthopaedic Sales Increases By Product Segment: 2010 vs. 2009

A First Look at 2010 Results: ConMed
CONMED $430.7MM, +4% * Arthroscopy $288.4MM, +5% * Powered Surgical Instruments $142.3MM, -3% * Expects single-use arthroscopy business will continue to lead growth as economy continues to improve * Not losing market share in su...
BARE BONES® - January 15, 2011
HEALTHTRUST awarded a multi-year purchasing agreement to CONMED LINVATEC for endoscopic imaging products. HealthTrust supports ~1,400 acute care facilities and 10,600 ambulatory surgery centers, physician practices and alternate care sites. (CONMED Corporation, 12/7/10)
BARE BONES® - November 10, 2010
ORTHOPAEDIC STRATEGIC INITIATIVESCANNUFLOW signed a master distribution and strategic alliance agreement with SYMMETRY MEDICAL’s SPECIALTY SURGICAL INSTRUMENT division (SSI), whereby Cannuflow is SSI’s exclusive supplier of arthroscopy fluid management and access disposabl...
ORTHOKNOW® - November 10, 2010
QUARTERLY REVIEW3Q10 Company FinancialsHere is the first look at select company financials for 3Q. Our estimates place year over year overall market growth at 4%, as indicated in Exhibit 1, which displays growth by product segment. Performance highlights relate to 3Q10, unless o...
ORTHOKNOW® - August 11, 2010
QUARTERLY REVIEWCompany FinancialsHere we present the first look at 2Q10 financial reports. Our estimates place overall market growth at 5% over 2Q09, as seen in Exhibit 1, which also displays 2Q orthopaedic sales growth by product segment for select companies. Performance highl...
ORTHOKNOW® - May 11, 2010
QUARTERLY REVIEW    The First Reports are InThe first wave of 1Q10 results have come in, and our estimates place overall market growth at 7% over 1Q09. Exhibit 1 shows 1Q orthopaedic sales growth by product segment for select companies, and is followed by performance highligh...
BARE BONES® - April 9, 2010
ORTHOPAEDIC STRATEGIC INITIATIVESALPHATEC SPINE closed its previously announced acquisition of SCIENT’X. (Alphatec Holdings, Inc., 3/29/10)ARTHREX acquired IBALANCE MEDICAL and will commence worldwide marketing of the IBalance HTO System, designed for use in pr...
ORTHOKNOW® - February 10, 2010
YEARLY REVIEWA First Look at 2009 ResultsAt press time, four of the major recon companies had reported 2009 financials. Their year-over-year growth is shown in Exhibit 1, and in the next issue, we will add in results reported during this month to present the fuller picture...
BARE BONES® - December 10, 2009
ORTHOPAEDIC STRATEGIC INITIATIVESADVANCED BIOMEDICAL TECHNOLOGIES (ABT) signed cooperative agreements for research and animal tests of its Cranio-Maxillofacial Fracture Treatment and Craniofacial Reconstruction utilizing ABT-CHANGHUA’s polyamide bio-absorbable material. (A...
ORTHOKNOW® - November 10, 2009
QUARTERLY REVIEW3Q09: Seasonality and StabilizationCompanies’ comments on 3Q09 ran the expected gamut, claiming impact of seasonality here and there, but still mentioning early signs of stabilization and cautious optimism. The overarching buzz seems to remain bullish.
  • 8401 Chagrin Road, Suite 18
  • Chagrin Falls, Ohio 44023 USA
  • Phone: 440.543.2101 • Fax: 440.543.2122
  • ©1992-2019 ORTHOWORLD
  • All Rights Reserved.
  • Site Managed By:
  • Open Professional Group